G. Ben-Baruch

发表

MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.

B. Davidson, W. Gotlieb, R. Reich, 1999, Gynecologic oncology.

Palliative urinary diversion in patients with malignant ureteric obstruction due to gynaecological cancer

Y. Inbar, Z. Dotan, S. Apter, 2019, BMJ Supportive & Palliative Care.

Characterization of the prenylated protein methyltransferase in human endometrial carcinoma.

Y. Kloog, D. Marciano, M. Altaras, 1994, Biochimica et biophysica acta.

Placental site trophoblastic tumor: outcome of five cases including fertility preserving management.

W. Gotlieb, R. Machtinger, M. Goldenberg, 2005, Gynecologic oncology.

Cystectomy for immature teratoma of the ovary.

W. Gotlieb, A. Shrim, E. Fridman, 2004, Gynecologic oncology.

Uterine Leiomyosarcoma: Does the Primary Surgical Procedure Matter?

E. Fridman, S. Sadetzki, G. Ben-Baruch, 2008, International Journal of Gynecologic Cancer.

Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma.

E. Sivan, D. Seidman, G. Ben-Baruch, 1996, Gynecologic oncology.

Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates

E. Friedman, G. Ben-Baruch, T. Perri, 2017, Journal of gynecologic oncology.

Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer.

B. Shalmon, W. Gotlieb, G. Ben-Baruch, 2003, Obstetrics and gynecology.

Outpatient endometrial sampling with the Pipelle curette.

E. Schiff, D. Seidman, G. Ben-Baruch, 1994, Gynecologic and obstetric investigation.

PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.

B. Davidson, W. Gotlieb, R. Reich, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treating Gynecologic Malignancies in Elderly Patients

G. Ben-Baruch, T. Perri, J. Korach, 2015, American journal of clinical oncology.

CA 125 measurement and ultrasonography in borderline tumors of the ovary.

B. Davidson, W. Gotlieb, Y. Zalel, 2000, American journal of obstetrics and gynecology.

An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews.

B. Modan, M. Papa, E. Friedman, 1998, British Journal of Cancer.

The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.

B. Modan, M. Papa, R. Gershoni-baruch, 1998, Human molecular genetics.

Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study.

J. Nesland, A. Berner, B. Davidson, 2001, Gynecologic oncology.

Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer.

B. Modan, E. Friedman, A. Chetrit, 2005, Gynecologic oncology.

Frequency and prediction of deep uterine involvement in advanced high-grade epithelial ovarian cancer: is uterine preservation an option?

G. Ben-Baruch, T. Perri, J. Korach, 2020, International Journal of Gynecological Cancer.

Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?

L. Hogen, R. Shapira-Frommer, G. Ben-Baruch, 2013, Gynecologic oncology.

Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries.

M. Gavish, Y. Kloog, Y. Katz, 1990, Clinical science.

Lack of correlation between 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and lovastatin resistance in nerve growth factor treated PC-12 cells

Y. Kloog, G. Ben-Baruch, J. Roitelman, 1994, Cellular and Molecular Neurobiology.

Ulex Europaeus Lectin and Anti‐CD31 Staining in Squamous Cell Carcinoma of the Uterine Cervix: Potential Prognostic Markers

B. Davidson, W. Gotlieb, I. Goldberg, 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The use of aspirin to prevent pregnancy‐induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies

E. Ruppin, E. Schiff, M. Goldenberg, 1989, The New England journal of medicine.

Endothelin‐1 receptors in the human myometrium: evidence for different binding properties in post‐menopausal as compared to premenopausal and pregnant women

E. Schiff, S. Mashiach, R. Galron, 1993, Clinical endocrinology.

Doxorubicin levels in the serum and ascites of patients with ovarian cancer.

B. Davidson, W. Gotlieb, A. Andersen, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Intraperitoneal chemotherapy versus no treatment in patients with ovarian carcinoma who are in complete clinical remission

G. Ben-Baruch, J. Menczer, S. Rizel, 1992, Cancer.

Intraperitoneal cisplatin chemotherapy in ovarian carcinoma patients who are clinically in complete remission.

G. Ben-Baruch, J. Menczer, S. Rizel, 1992, Gynecologic oncology.

Endothelin-1 receptors on the human placenta and fetal membranes: evidence for different binding properties in pre-eclamptic pregnancies.

E. Schiff, S. Mashiach, R. Galron, 1993, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Immunoreactive circulating endothelin-1 in normal andhypertensive pregnancies

E. Schiff, T. Rosenthal, E. Peleg, 1992 .

Use of Titanium Spiral Tacks for Long-term Oophoropexy Before Pelvic Irradiation

L. Hogen, S. B. Haim, D. Meirow, 2014, International Journal of Gynecologic Cancer.

Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second look laparotomy. A reassessment based on mature data.

G. Ben-Baruch, J. Menczer, S. Rizel, 1989, European journal of gynaecological oncology.

Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after. Second‐look laparotomy

M. Modan, G. Ben-Baruch, J. Menczer, 1989, Cancer.

Extraperitoneal metastases after intraperitoneal chemotherapy of ovarian cancer patients with a negative second-look laparotomy

G. Ben-Baruch, J. Menczer, S. Rizel, 1992, International Journal of Gynecologic Cancer.

Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention.

L. Hogen, D. Rosin, G. Ben-Baruch, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prolonged Conservative Treatment of Endometrial Cancer Patients: More Than 1 Pregnancy Can Be Achieved

A. Ferenczy, W. Gotlieb, D. Meirow, 2010, International Journal of Gynecologic Cancer.

Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib

Y. Kloog, G. Ben-Baruch, R. Haklai, 2013, Oncotarget.

The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies.

E. Ruppin, E. Schiff, M. Goldenberg, 1990, The New England journal of medicine.

MRgFUS for pain relief as palliative treatment in recurrent cervical carcinoma: a case report.

R. Machtinger, Y. Inbar, J. Rabinovici, 2008, Gynecologic oncology.

Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.

J. Nesland, A. Berner, B. Davidson, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Familial ovarian cancer in Israeli Jewish women.

G. Ben-Baruch, J. Menczer, 1991 .

Transvaginal color flow imaging in the diagnosis of ovarian tumors.

L. Lerner-Geva, I. Cohen, Y. Beyth, 1995, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Impaired binding properties of endothelin‐1 receptors in human endometrial carcinoma tissue

E. Schiff, R. Galron, G. Ben-Baruch, 1993, Cancer.

Promising Effect of Aromatase Inhibitors on Recurrent Granulosa Cell Tumors

E. Fridman, G. Ben-Baruch, T. Perri, 2009, International Journal of Gynecologic Cancer.

Prenylated protein methyltransferase of rat cerebellum is developmentally co‐expressed with its substrates

Y. Kloog, D. Marciano, G. Ben-Baruch, 1993, FEBS letters.

E-Cadherin complex protein expression and survival in ovarian carcinoma.

J. Nesland, A. Berner, B. Davidson, 2000, Gynecologic oncology.

Cystotomy--for facilitation of optimal resection of adherent pelvic tumors.

E. Sivan, E. Schiff, G. Ben-Baruch, 1991, Gynecologic oncology.

Borderline tumors of the ovary

B. Davidson, W. Gotlieb, J. Kopolovic, 1998, Cancer.

Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer.

W. Gotlieb, G. Ben-Baruch, Y. Segal, 1998, Gynecologic oncology.

Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.

W. Gotlieb, Y. Yinon, G. Ben-Baruch, 2007, Fertility and sterility.

Fertility preservation in women with borderline ovarian tumors – how does it impact disease outcome? A cohort study

S. Aviel-Ronen, G. Ben-Baruch, T. Perri, 2017, Acta obstetricia et gynecologica Scandinavica.

Borderline tumors of the ovary

B. Davidson, W. Gotlieb, J. Kopolovic, 1998, Cancer.

Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.

S Wacholder, B. Modan, P. Hartge, 2001, The New England journal of medicine.

Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors.

B. Modan, E. Friedman, B. Davidson, 1998, Journal of the National Cancer Institute.

High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian Cancer.

B. Modan, M. Papa, E. Friedman, 1996, JAMA.

Expression of Metalloproteinases and Their Inhibitors in Adenocarcinoma of the Uterine Cervix

B. Davidson, W. Gotlieb, R. Reich, 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The Ras AntagonistS-Farnesylthiosalicylic Acid Induces Inhibition of MAPK Activation

Y. Kloog, D. Marciano, G. Ben-Baruch, 1997 .

Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: A possible activation pathway?

B. Davidson, W. Gotlieb, B. Risberg, 2003, Cancer and Metastasis Reviews.

Expression of angiogenesis-related genes in ovarian carcinoma – A clinicopathologic study

J. Nesland, A. Berner, B. Davidson, 2004, Clinical & Experimental Metastasis.

The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma

J. Nesland, B. Davidson, W. Gotlieb, 2002, Molecular and Cellular Endocrinology.

Cyst Fluid CA 125 Levels in Ovarian Epithelial Neoplasms

S. Lipitz, G. Ben-Baruch, J. Menczer, 1993, Obstetrics and gynecology.

Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma.

E. Friedman, W. Gotlieb, S. Mahmud, 2009, Cancer genetics and cytogenetics.

Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy

R. Machtinger, M. Goldenberg, E. Fridman, 2004, International Journal of Gynecologic Cancer.

Familial vs sporadic ovarian tumors: characteristic genomic alterations analyzed by CGH.

E. Friedman, W. Gotlieb, O. Israeli, 2003, Gynecologic oncology.

High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

J. Nesland, A. Berner, B. Davidson, 2004, Clinical & Experimental Metastasis.

Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in Israel.

I. Barshack, E. Friedman, A. Chetrit, 2000, European journal of cancer.

Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel.

E. Friedman, W. Gotlieb, A. Aviram, 2000, Cancer genetics and cytogenetics.

Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.

J. Nesland, J. Nesland, A. Berner, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice

Y. Kloog, P. Gierschik, K. Giehl, 1999, Oncogene.

Endometrial carcinoma developing after cervical amputation: the influence of cervical stenosis on prognosis.

I. Bukovsky, D. Schneider, A. Golan, 1994, European journal of gynaecological oncology.

Villoglandular papillary adenocarcinoma of the uterine cervix: A diagnostic challenge

E. Fridman, R. Machtinger, D. Vicus, 2009, Acta obstetricia et gynecologica Scandinavica.

Expression of topoisomerase II and Ki‐67 in cervical carcinoma — clinicopathological study using immunohistochemistry

I. Novikov, B. Davidson, W. Gotlieb, 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Immediate and Late Outcome of Vaginal Myomectomy for Prolapsed Pedunculated Submucous Myoma

E. Schiff, G. Ben-Baruch, J. Menczer, 1988, Obstetrics and gynecology.

Curettage vs. nonsurgical management in women with early spontaneous abortions. The effect on fertility.

E. Schiff, S. Mashiach, G. Ben-Baruch, 1991, The Journal of reproductive medicine.

Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma.

S. Elizur, J. Dor, G. Ben-Baruch, 2007, Fertility and sterility.

In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer.

E. Friedman, O. Israeli, S. Rienstein, 2005, Cancer genetics and cytogenetics.

Reduction of thromboxane A2 synthesis in pregnancy by polyunsaturated fatty acid supplements

E. Schiff, T. Rosenthal, E. Peleg, 1993, American journal of obstetrics and gynecology.

Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.

B. Modan, J. Struewing, E. Friedman, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ras antagonist inhibits growth and chemosensitizes human epithelial ovarian cancer cells

Y. Kloog, G. Ben-Baruch, R. Haklai, 2005, International Journal of Gynecologic Cancer.

Growth inhibition of ras‐dependent tumors in nude mice by a potent ras‐dislodging antagonist

Y. Kloog, G. Ben-Baruch, M. Gana‐Weisz, 1999, International journal of cancer.

FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors.

I. Barshack, S. Aviel-Ronen, Y. Cohen, 2011, Gynecologic oncology.

Standardized Measurement of Amniotic Fluid Volume by Correlation of Sonography With Dye Dilution Technique

E. Schiff, S. Mashiach, G. Ben-Baruch, 1990, Obstetrics and gynecology.

Malignant Pericardial Effusion in Ovarian Malignancy: A Treatable Oncologic Emergency.

G. Ben-Baruch, T. Perri, J. Korach, 2015, The Journal of emergency medicine.

Selective Inhibition of Ras-dependent Cell Growth by Farnesylthiosalisylic Acid (*)

Y. Kloog, D. Marciano, G. Ben-Baruch, 1995, The Journal of Biological Chemistry.

Cooperativity pattern in the interaction of the antiestrogen drug clomiphene with the Muscarinic receptors.

G. Schreiber, G. Ben-Baruch, M. Sokolovsky, 1982, Molecular pharmacology.

Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.

J. Nesland, A. Berner, B. Davidson, 2000, Gynecologic oncology.

Primary infertility in women exposed to diethylstilboestrol in utero

M. Modan, M. Dulitzky, G. Ben-Baruch, 1986 .

Primary infertility in women exposed to diethylstilboestrol in utero

M. Modan, M. Dulitzky, G. Ben-Baruch, 1986, British journal of obstetrics and gynaecology.

Macrophage infiltration and angiogenesis in cervical squamous cell carcinomaclinicopathologic correlation

B. Davidson, W. Gotlieb, I. Novikov, 1999, Acta obstetricia et gynecologica Scandinavica.

Anti-Mesothelin Antibodies and Circulating Mesothelin Relate to the Clinical State in Ovarian Cancer Patients

E. Swisher, E. Friedman, I. Hellstrom, 2008, Cancer Epidemiology Biomarkers & Prevention.

Topoisomerase II immunostaining as a prognostic marker for survival in ovarian cancer.

B. Davidson, W. Gotlieb, I. Novikov, 2001, Gynecologic oncology.

Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.

B. Davidson, W. Gotlieb, R. Reich, 1999, Gynecologic oncology.

Cisplatin excretion in human milk.

G. Ben-Baruch, R. Gorodetsky, J. Menczer, 1992, Journal of the National Cancer Institute.

Subfertility, use of fertility treatments and BRCA mutation status and the risk of ovarian cancer

B. Modan, E. Friedman, A. Chetrit, 2022, Archives of Gynecology and Obstetrics.

Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers.

E. Friedman, S. Sadetzki, D. Meirow, 2015, Fertility and sterility.

Infertility treatment after conservative management of borderline ovarian tumors

B. Davidson, W. Gotlieb, J. Kopolovic, 2001, Cancer.

Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors.

S. Aviel-Ronen, L. Hogen, G. Ben-Baruch, 2015, Fertility and sterility.

Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth.

Y. Kloog, D. Marciano, G. Ben-Baruch, 1995, Journal of medicinal chemistry.

Malignancies following bilateral salpingo-oophorectomy (BSO).

M. Barchana, G. Ben-Baruch, E. Friedman, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

CT of pelvic infection after cesarean section.

S. Apter, G. Barkai, G. Ben-Baruch, 1992, Clinical and experimental obstetrics & gynecology.

Importance of accurate preoperative diagnosis in the management of aggressive angiomyxoma: report of three cases and review of the literature

W. Gotlieb, E. Fridman, S. Apter, 2006, Abdominal Imaging.

Major surgical complications of laparoscopy.

G. Ben-Baruch, J. Menczer, Y. Frenkel, 1981, European journal of obstetrics, gynecology, and reproductive biology.

Expression of Matrix Metalloproteinase-9 in Squamous Cell Carcinoma of the Uterine Cervix—Clinicopathologic Study Using Immunohistochemistry and mRNAin SituHybridization

B. Davidson, W. Gotlieb, R. Reich, 1999 .

Abdominopelvic irradiation for stage II-IV ovarian carcinoma patients with limited or no residual disease at second-look laparotomy after completion of cisplatinum-based combination chemotherapy.

M. Modan, G. Ben-Baruch, J. Menczer, 1986, Gynecologic oncology.

Pyosalpinx Subsequent to Tubal Ligation

J. Sarlin, G. Ben-Baruch, M. Tamarkin, 1989, Acta Obstetricia et Gynecologica Scandinavica.

Ligand‐independent regulation of ErbB4 receptor phosphorylation by activated ras

Y. Kloog, R. Pinkas-Kramarski, Y. Goldshmit, 2006, Journal of cellular biochemistry.

The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma.

B. Modan, J. Gaynor, L. Lerner, 1995, American journal of obstetrics and gynecology.

A life-threatening sexually transmitted Haemophilus influenzae in septic abortion: a case report.

B. Reichman, E. Schiff, S. Mashiach, 1991, American journal of obstetrics and gynecology.

Genomic analyses of primary and metastatic serous epithelial ovarian cancer.

E. Friedman, W. Gotlieb, O. Israeli, 2004, Cancer genetics and cytogenetics.

Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.

B. Modan, J. Struewing, E. Friedman, 2000, Gynecologic oncology.

Transvaginal color Doppler ultrasound in the assessment of invasive cervical carcinoma.

Y. Zalel, Y. Beyth, R. Tepper, 1996, Gynecologic oncology.

Effect of Treatment Delay on Survival in Patients With Cervical Cancer: A Historical Cohort Study

L. Hogen, G. Ben-Baruch, T. Perri, 2014, International Journal of Gynecologic Cancer.

Prediction of pregnancy-induced hypertension by a combination of rollover test and Doppler flow velocity measurement.

E. Schiff, M. Goldenberg, S. Mashiach, 1991, Journal of perinatal medicine.

Frequency and prediction of deep uterine involvement in advanced high-grade epithelial ovarian cancer: is uterine preservation an option?

G. Ben-Baruch, T. Perri, J. Korach, 2020, International Journal of Gynecological Cancer.

Altered ontogenesis of muscarinic cholinergic receptor in mouse brain: effect of L-thyroxine and betamethasone.

Y. Kloog, S. Mashiach, G. Ben-Baruch, 1981, Endocrinology.

Imaging of pelvic postpartum complications.

S. Apter, G. Ben-Baruch, M. Hertz, 1998, AJR. American journal of roentgenology.

Dermatomyositis following the diagnosis of ovarian cancer.

N. Agmon-Levin, M. Huszar, Z. Sthoeger, 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Immunoreactive circulating endothelin‐1 in normal and hypertensive pregnancies

E. Schiff, E. Peleg, S. Mashiach, 1992, American journal of obstetrics and gynecology.

Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.

I. Cohen, Y. Beyth, R. Tepper, 1994, Gynecologic oncology.

Sonographic and Doppler flow characteristics of ovarian tumors of low‐malignant potential

Y. Zalel, I. Cohen, Y. Beyth, 1997, Journal of clinical ultrasound : JCU.

Uterine sarcomas in Israeli patients: a clinicopathological study.

G. Ben-Baruch, J. Menczer, G. Amir, 1984, Israel journal of medical sciences.

Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension.

E. Schiff, G. Barkai, S. Mashiach, 1990 .

Familial ovarian cancer in Israeli Jewish women

G. Ben-Baruch, J. Menczer, 1991, Obstetrics and gynecology.